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Summary
The regulation of gene expression by microRNAs (miRNAs) is
critical for normal development and physiology. Conversely,
miRNA function is frequently impaired in cancer, and other
pathologies, either by aberrant expression of individual miRNAs
or dysregulation of miRNA synthesis. Here, we have investigated
the impact of global disruption of miRNA biogenesis in primary
fibroblasts of human or murine origin, through the knockdown
of DGCR8, an essential mediator of the synthesis of canonical
miRNAs. We find that the inactivation of DGCR8 in these cells
results in a dramatic antiproliferative response, with the acqui-
sition of a senescent phenotype. Senescence triggered by DGCR8
loss is accompanied by the upregulation of the cell-cycle inhibitor
p21CIP1. We further show that a subset of senescence-associated
miRNAs with the potential to target p21CIP1 is downregulated
during DGCR8-mediated senescence. Interestingly, the antiprolif-
erative response to miRNA biogenesis disruption is retained in
human tumor cells, irrespective of p53 status. In summary, our
results show that defective synthesis of canonical microRNAs
results in cell-cycle arrest and cellular senescence in primary
fibroblasts mediated by specific miRNAs, and thus identify global
miRNA disruption as a novel senescence trigger.
Key words: DGCR8; fibroblasts; microRNA; p21CIP1; p53;
senescence.
Introduction
Tumors arise as a consequence of the malfunction of critical regulators
of normal cellular homeostasis, which results in aberrant proliferation
and other tumor-associated traits. Genetic studies in cancer have long
focused on genes that code for proteins. However, in recent years, it has
become increasingly clear the essential role of regulatory noncoding
RNAs, such as microRNAs (miRNAs) or long noncoding RNAs (lncRNAs) in
cancer and other human pathologies. These regulatory RNAs play a key
role in the control of cellular functions critically altered in tumor
formation and progression, and accordingly their deregulation is an
almost universal feature of tumors (Esteller, 2011; Lujambio & Lowe,
2012). MicroRNAs are small noncoding RNAs (18–25 nucleotides) that
negatively regulate their target genes, primarily through RNA destabi-
lization and inhibition of translation. The synthesis of mature microRNAs
involves a series of coordinated steps in the nucleus and cytoplasm
(Winter et al., 2009). A primary transcript (pri-miRNA) is initially
generated by RNA polymerase II from independent miRNA units or
clusters located in the introns of protein-coding genes, or other genomic
locations. The primary transcript is processed in the nucleus by a complex
formed by the ribonuclease Drosha, and the auxiliary protein DGCR8
(also known as Pasha) to generate 60- to 70-bp-long RNA hairpins,
known as pre-miRNA. An alternative, noncanonical pathway leads to the
generation of pre-miRNA molecules from splicing of intron-encoded
precursors, mirtrons, without the participation of the Drosha-DGCR8
complex. pre-miRNAs are subsequently exported to cytoplasm where
they are further processed by Dicer and loaded into the RNA-induced
silencing complex (RISC) to produce destabilization and translational
inhibition of target genes (Guo et al., 2010). Aberrant miRNA expression
is a common trend of human cancers. There are many examples of
individual miRNAs with deregulated expression in tumors, which play
both positive and negative roles in tumor formation or progression
(Esteller, 2011; Lujambio & Lowe, 2012). In addition, global regulation of
miRNA biogenesis can also be altered during tumorigenesis, as shown by
the deregulation in tumors of key miRNA-processing factors (Esteller,
2011; Lujambio & Lowe, 2012). Cellular senescence is increasingly
recognized as an essential tumor-suppressive mechanism that restrains
uncontrolled proliferation of cells harboring potentially oncogenic
alterations. Senescence can be induced by a large series of alterations
in normal cellular homeostasis associated with tumorigenesis, including
activation of oncogenes, DNA-damage, telomere dysfunction, or inac-
tivation of tumor suppressor genes (Serrano et al., 1997; Collado &
Serrano, 2010; Kuilman et al., 2010). Here, we set to study the global
impact of miRNA biogenesis in primary cells, using the specific
knockdown of DGCR8, a key regulator of canonical miRNAs synthesis.
We find that disrupted microRNA synthesis results in a senescence-like
antiproliferative response in primary fibroblasts, as a consequence of the
deregulation of key miRNAs linked to the cell-cycle machinery, and this
response is essentially retained in tumor cell lines.
Results
Disruption of miRNA biogenesis blocks proliferation in
primary cells
To study the global role of miRNA-mediated gene regulation in
nontransformed, primary cells, we inhibited miRNA biogenesis by stable
silencing of key regulators of this pathway in primary fibroblasts. First,
early-passage IMR90 human primary fibroblasts were infected with
vectors expressing shRNAs against DGCR8, which efficiently reduced
endogenous DGCR8 mRNA and protein levels (Fig. 1A, left and
Fig. S1A). Inactivation of DGCR8 dramatically reduced the proliferation
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rate of these cells, as shown by their cummulative growth curves and
their rate of BrdU incorporation (Fig. 1B). The antiproliferative effect was
also evident in long-term growth assays, or in studies using low cell
density (Figs 1D and S1B). Consistent results were obtained using two
independent shRNAs targeting DGCR8 (Fig. 1B). Similar results were
obtained with shRNAs against Drosha and Dicer, two additional key
regulators of miRNA biogenesis (Fig. S1A,C,D) further confirming that
the phenotype observed was triggered by disruption of miRNA biogen-
esis. To test the generality of these observations, we also inactivated
DGCR8 in early-passage wild-type mouse embryo fibroblasts (MEF) using
a retroviral shRNA vector (Fig. 1A, right). Similar to human fibroblasts,
stable silencing of DGCR8 in MEFs resulted in reduced BrdU incorpo-
ration and proliferation rate, relative to control MEFs, although the effect
was less dramatic than that seen with human fibroblasts (Fig. 1C). This
set of results indicates that global disruption of miRNA biogenesis blocks
proliferation of primary fibroblasts.
Induction of senescence in DGCR8-deficient fibroblasts
Having shown that disruption of miRNA biogenesis in fibroblasts triggers
an antiproliferative response, we wanted to characterize the mechanism
responsible for this arrest in shDGCR8 fibroblasts. During the course of
our experiments, we noticed that shDGCR8 IMR90 fibroblasts under-
went changes in morphology that were reminiscent of those of
senescent fibroblasts. Cellular senescence is an antiproliferative response
and tumor-suppressive barrier, which can be triggered by a variety of
potentially oncogenic changes in cellular homeostasis (Collado &
Serrano, 2010). We hypothesized that the disruption of miRNA
biogenesis could activate senescence, thus explaining the proliferative
defect observed. To test this hypothesis, we assayed several well-
established markers of the senescent phenotype. As mentioned, IMR90
cells expressing shDGCR8 acquired a characteristic flat morphology,
typical of senescent fibroblasts, in contrast to the long elongated shape
of nonsenescent human fibroblasts. Similarly, shDGCR8 IMR90 cells also
showed a significant increase in the number of cells with senescent-
associated beta-galactosidase (SA-Beta Gal) activity (Fig. 2A) as well as
nuclei with SAHFs (senescence-associated heterochromatin foci), regions
of facultative heterochromatin characteristic of senescent cells (Fig. 2B).
Taken together, these results indicate that the depletion of DGCR8 leads
to premature senescence in IMR90 human fibroblasts. Prompted by
these results, we also studied whether silencing of DGCR8 could induce
a senescent phenotype in MEFs, a cell type where we had also observed
reduced proliferation by shDGCR8. As shown in Figure 2C, DGCR8-
deficient wild-type MEFs also acquired a senescent phenotype, as
indicated by a clear increase in cells positive for SA-Beta Gal activity and
with flattened morphology. To identify possible mediators of the
phenotype of DGCR8-deficient cells, we carried out Western Blot
analysis of key regulators of cell cycle and senescence in MEFs and IMR90
fibroblasts. Inactivation of DGCR8 in human and murine fibroblasts
caused a modest, but reproducible increase in the protein levels of the
cell-cycle inhibitor p21CIP1 (Figs 2D and E). Also, a 3-fold increase in
p21CIP1 transcript (Fig. 2F) and increased number of p21CIP1-positive
cells by immunofluorescence (Fig. 2G) was observed in shDGCR8 human
fibroblasts. Of note, p21CIP1 is frequently upregulated and contributes
to cell-cycle arrest during senescence (Brown et al., 1997), and it is
directly regulated by miRNAs (Ivanovska et al., 2008; Wu et al., 2010).
We did not observe significant changes in p53 or p16 protein levels in
either cell type after DGCR8 silencing (Fig. 2D,E and data not shown).
Mediators of DGCR8-induced senescence
To characterize further, the mechanism behind the induction of
senescence by miRNA disruption, we tried to identify potential mediators
of the response. For human fibroblasts, we focused on the p53 and p16/
Rb pathways, key tumor suppressors, which play a critical role in the
implementation of senescence in this cell type (Serrano et al., 1997;
Collado & Serrano, 2010). To this end, we combined shDGCR8 with
specific shRNAs against p53 or Rb, to achieve stable independent
inactivation of each pathway. shRNAs against p16INK4A were also used
in some experiments to target the p16/Rb pathway, giving undistin-
guishable results (data not shown). Efficient silencing of each protein was
achieved, while endogenous p53 or Rb protein levels were not signifi-
cantly affected by DGCR8 downregulation (Fig. S2A). IMR90 cells
deficient for Rb or p53 drastically reduced proliferation upon DGCR8
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Fig. 1 Antiproliferative effect of abrogation of DGCR8 in fibroblasts. (A) Western
blot showing silencing efficiency of sh-DGCR8 vectors. (B) Growth curve, top, and
BrdU incorporation rate (bottom) of IMR-90 human fibroblasts infected with two
different sh-DGCR8 vectors (dots in top panel) or empty vector (black squares).
(C) Growth curve, top, and BrdU incorporation rate (bottom) of wild-type mouse
embryo fibroblasts infected with a sh-DGCR8 vector or empty vector. (D) Crystal
violet staining of IMR-90 human fibroblasts retrovirally infected with two sh-
DGCR8 vectors or empty vector. (B,C) bottom panels show the average and SD of
at least three independent experiments.
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inactivation, to a similar extent as parental IMR90 fibroblasts, as
measured by BrdU incorporation rate. Similarly, shp53 or shRb IMR90
fibroblasts expressing shDGCR8 acquired senescent markers, such as
enlarged morphology, SA-Beta Gal activity or SAHFs to an extent
comparable to control fibroblasts (Fig. 3A–D). Collectively, these results
indicate that depletion of DGCR8 can induce a senescent phenotype in
human primary fibroblasts that is mainly p53 and Rb independent. Similar
analyses were performed in mouse fibroblasts, using p53-knockout and
p21-knockout MEFs, the latter due to the increase in p21 observed in
response to DGCR8 deficiency. We confirmed that high efficiency of
DGCR8 silencing was obtained in all the genotypes (Fig. 3E). Growth
curves and BrdU incorporation assays revealed that p53-knockout MEFs
were less responsive to DGCR8 silencing than wild-type counterparts.
Instead, p21 knockout MEFs showed a reduction in proliferation
comparable to wild-type MEFs (Fig. 3F,G). These results with human
and mouse fibroblasts are consistent with the notion that p53 disruption
suffices to bypass senescence in murine fibroblasts, whereas simulta-
neous inactivation of both the Rb and p53 pathways is generally required
for that effect in human fibroblasts (Serrano et al., 1997).
Mechanism of senescence activation in DGCR8-deficient
primary cells
To distinguish which could be the mechanism linking DGCR8-deficiency
to senescence, we considered several hypotheses. First, we asked
if the phenotype could be caused by Ras-induced senescence.
Sustained mitogenic signaling due to activated Ras oncogene is a
well-characterized trigger for cellular senescence in fibroblasts and
other cell types (Serrano et al., 1997). In addition, it has been shown
that Ras expression is regulated by the let-7 miRNA family, providing a
direct link between miRNA function and Ras activity (Johnson et al.,
2005). To test this hypothesis, we measured Ras levels and phosphor-
ylation of the downstream Ras effectors ERK1/2 in shDGCR8 fibro-
blasts. Although we observed a transient increase in Ras protein levels
and ERK phosphorylation in some experiments with shDGCR8 wild-type
MEFs, we failed to detect consistent activation of the Ras pathway (Fig.
S2B). p19Arf accumulates dramatically in MEFs upon oncogenic Ras
expression or other pro-senescent stimuli (Zindy et al., 1997; Palmero
et al., 1998). We found that p19Arf was unchanged or even
downregulated in shDGCR8 MEFs in our experiments (Figs 2E and
S2B), arguing against the occurrence of canonical oncogene-induced
senescence in these cells. In addition, shDGCR8 MEFs that lacked p21
or p53 did not show clear changes in Ras protein or its signaling
pathway, with similar p19Arf levels. On the other hand, DGCR8-
deficient IMR90 cells did not show significant changes in the Ras
pathway or induction of the p16INK4A protein (the INK4A/ARF product
more commonly activated during senescence in this cell type, data not
shown). As an alternative explanation for the senescent phenotype, we
also investigated if suppression of DGCR8 could lead to DNA damage,
a potential trigger of senescence (Di Micco et al., 2006). We did not
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Fig. 2 Induction of senescence markers in sh-DGCR8 fibroblasts. (A,B) SA-Beta Gal and SAHFs in IMR-90 fibroblasts expressing sh-DGCR8 or empty vector. (B) two
representative images and the percentage of SAHF-positive cells are indicated. (C) SA-Beta Gal staining in mouse embryo fibroblasts expressing sh-Dgcr8 or empty vector.
(D,E) Western blot analysis of the indicated proteins in human, (D) and murine, (E) fibroblasts expressing sh-DGCR8 vectors or empty vector controls. (F) QPCR analysis of
transcript levels for p21CIP1 in human IMR-90 fibroblasts. The average and standard deviation from three experiments is shown. (G) Number of IMR90 cells positive for
p21CIP1 by immunofluorescence.
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observe significant changes in the DNA-damage marker gamma-H2AX,
in shDGCR8 human fibroblasts of two different strains (Fig. S3B).
Likewise, no gross changes were noticed in chromatin or nuclear
structure after silencing of DGCR8 in murine or human fibroblasts
(leaving aside appearance of SAHFs in IMR90, Fig. S3A). Collectively,
these results suggest that activation of Ras-induced senescence or DNA
damage cannot account for the arrest triggered by shDGCR8 in
primary fibroblasts.
Role of specific miRNAs in DGCR8-induced arrest
Studies with mice genetically defective for Dgcr8 (Stark et al., 2008;
Wang et al., 2008) have shown that, despite the general deregulation of
miRNAs, the proliferation defects associated with loss of DGCR8 can be
traced to a subset of individual miRNAs. In order to identify specific
miRNAs that could be mediating the phenotype triggered by DGCR8-
dependent disruption of miRNA biogenesis, we analyzed the expression
of individual miRNAs in IMR90 fibroblasts upon DGCR8 suppression. As a
first step, we identified a set of miRNAs downregulated in IMR90
fibroblasts made senescent by tamoxifen-inducible activation of MEK
(Fig. 4A). Interestingly, we noted a significant overlap between this set
of senescence-regulated miRNAs and those associated to cell-cycle
defects in DGCR8-null embryonic stem cells and early embryos (Wang
et al., 2007, 2008). With this rationale, we focused on the miRNAs miR-
20a, miR-93 and miR-106a as potential mediators of DGCR8-induced
senescence. The expression analysis of this subset of miRNAs in IMR90
fibroblasts showed that they were significantly downregulated during
DGCR8-mediated arrest (Fig. 4B). All these miRNAs share a common
seed sequence, and two potential binding sites for them were identified
in the 3′UTR region of human p21CIP1 using two different prediction
tools, Targetscan and Pictar, (Fig. S4, see also Ivanovska et al., 2008;
Wang et al., 2008). Their ability to target the 3′UTR of the human
p21CIP1 transcript was subsequently confirmed in a luciferase reporter
assay (Fig. 4C). To test directly the participation of this set of miRNAs in
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Fig. 3 Molecular mediators of DGCR8-induced senescence. (A) Representative micrographs showing senescent morphology in IMR-90 fibroblasts, expressing the
indicated combinations of sh-RNA vectors. (B,C,D) BrdU incorporation rates (B), percentage of SA-BetaGal positive cells (C), or SAHF-positive nuclei (D), of IMR-90 cells
expressing the indicated combinations of sh-RNA vectors, 6 days after the end of drug selection. The average and standard deviation from three experiments is shown.
(E) Western blot analysis of the indicated proteins in wild-type, p21CIP1-KO or p53-KO MEFs, expressing an sh-Dgcr8 vector or empty vector. (F,G) Relative
BrdU incorporation and growth curve. The average and standard deviation from three experiments is shown in (F). (G) shows data from one representative experiment.
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DGCR8-induced senescence, we expressed them ectopically in combi-
nation with silencing of DGCR8. Of the three miRNAs tested, we focused
on miR-93, based on its degree of downregulation in shDGCR8 cells
(Fig. 4B) and the level of overexpression achieved (Fig. 4D and data not
shown). We found that ectopic miR-93 was able to bypass to different
extents the effect of shDGCR8 in IMR90 cells as measured by p21
induction, BrdU incorporation and SA-Beta Gal activity (Fig. 4E). These
results strongly suggest that this set of miRNAs are potential mediators
of the senescent phenotype and p21 induction triggered by defective
miRNA biogenesis.
DGCR8 deficiency causes arrest in cancer cells
Our findings show that a proficient miRNA-processing machinery is
essential for normal proliferation in primary fibroblasts, and its disruption
is sufficient to trigger cellular senescence. Based on these observations, we
asked if experimental manipulation of miRNA biogenesis could also be
exploited to block proliferation in tumor cells. To this end, DGCR8 was
silenced in the human colorectal cancerHCT116 cell line (Fig. 5A). Similarly
to human and mouse primary cells, DGCR8 depletion had a clear
antiproliferative effect in this tumor cell line as shown by a reduction of
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Fig. 4 Role of specific microRNAs. (A) QPCR of the indicated mature miRNAs in IMR-90 fibroblasts expressing a tamoxifen-inducible version of MEK (IMEK), with or
without 4-OH-tamoxifen (4OHT). The transcript levels relative to untreated cells are shown. (B) QPCR of the indicated mature miRNAs in IMR-90 fibroblasts expressing
sh-DGCR8, relative to vector-expressing cells. (C) Luciferase activity of p21CIP1 3′UTR luciferase reporter constructs, after cotransfection with the indicated miRNAs. The
vector referred as ‘miR-17 clust’ encodes the polycistronic miR-17-92 cluster, which includes miR-17 and miR-20a, among other miRNAs. The average and standard deviation
from two independent assays are shown. (D) QPCR of the indicated miRNAs in IMR-90 cells serially infected with vectors for shDGCR8 and ectopic miR-93, and
corresponding empty vectors. (E) QPCR of p21CIP1 (left), BrdU incorporation (centre), and percentage of SA-BetaGal-positive cells (right) in IMR-90 cells expressing
the indicated combinations of shRNA and ectopic miRNA vectors. (D,E) show data from one representative experiment.
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colony numbers (Fig. 5D), and in cell number (Fig. S5A). Silencing of
DGRC8 also led to an increase in p21, at protein andmRNA levels (Fig. 5A,
B). Similar results were obtained with additional human transformed or
immortalized cell lines (Fig. S5B, see also Gomez-Cabello et al., 2010). Of
note, the upregulation of p21protein in human tumoror immortalized cells
was more intense than that observed in primary fibroblasts (Figs 5A and
S5B). Interestingly, DGCR8 silencing in these cells resulted in a significant
decrease in expression of miR-20a, miR-93, andmiR-106a, the same set of
miRNAs deregulated in shDGCR8 human fibroblasts, (Fig. 5C). A p53-null
derivative of the HCT116 cell linewas also efficiently arrested by shDGCR8,
indicating that, similar to primary human fibroblasts, the antiproliferative
effect of shDGCR8 in tumor cell lines was retained in the absence of
functional p53 (Figs 5A,D and S5A). However, in contrast to primary
fibroblasts, the DGCR8-mediated arrest in HCT-116 cells was not accom-
panied bya clear inductionof classical senescencemarkers, such as SA-Beta
Gal staining, SAHF formation or morphology changes (data not shown).
Discussion
In this report, we have shown that the inactivation of DGCR8, an essential
regulator of biogenesis of canonical miRNAs, results in cell-cycle arrest in
primary fibroblasts, with the characteristic features of cellular senescence.
Our observations are in line with extensive genetic evidence in mouse
models with loss of function of miRNA regulators, which supports the
notion that disruption of miRNA production is detrimental for normal
development and proliferation. Thus, targeted disruption of the Dgcr8
locus in mice leads to embryonic lethality (Wang et al., 2007; Stark et al.,
2008) and defects in proliferation and differentiation in embryonic stem
cells (Wang et al., 2007, 2008; Stark et al., 2008). Similarly, specific
ablation of DGCR8 in diverse adult mouse tissues results in severe
proliferation and differentiation defects in the affected organs (Yi et al.,
2009; Fenelon et al., 2011; Chen et al., 2012). Our data suggest that the
arrest triggered by DGCR8 depletion is relayed mainly by the direct action
of specific miRNAs on the expression of senescence regulators, although
some contribution of alternative pathways remains possible. In particular,
we have identified a set of miRNAs that are potential mediators of the
senescence arrest, which could act, at least in part, by direct targeting of
the cell cycle and senescence mediator p21CIP1, which is consistently
upregulated in different shDGCR8-cells, albeit to varying extents. How-
ever, our results also suggest that additional factors must be involved. For
instance, p21 is not essential for the arrest, at least in murine fibroblasts.
The differential requirement of p21 could be related in part to the relative
impact of p21 in senescence in each cell type, as p21-null MEFs can
undergo normal replicative or oncogene-induced senescence (Pantoja &
Serrano, 1999), whereas p21 seems to have a stronger impact in human
fibroblast senescence (Brown et al., 1997; Borgdorff et al., 2010). In an
attempt to identify potential additional mediators of DGCR8-mediated
arrest, we have analyzed the expression of cell-cycle regulators in
shDGCR8 IMR90 fibroblasts using a QPCR array (Fig. S6). In this way, we
have identified a set of genes potentially regulated viamiRNAs in shDGCR8
cells, based on their upregulation relative to control cells and the presence
of predictedmiRNA-binding sites. The analysis confirmed the upregulation
of p21CIP1 at RNA level in shDGCR8 cells, serving as an internal control.
This result suggests that several cell-cycle proteins could cooperate with
p21CIP1, contributing directly or indirectly to the arrest triggered by
shDGCR8; however, further work would be needed to determine the
functional relevance of these genes in DGCR8-induced senescence.
Interestingly, the set of miRNAs with reduced expression during
DGCR8-mediated arrest are also downregulated during oncogene-
induced senescence (Fig. 4A), replicative senescence (Bonifacio &
Jarstfer, 2010; Marasa et al., 2010; Wang et al., 2011; Faraonio et al.,
2012) or DNA-damage induced senescence (Greussing et al., 2013) in
different strains of human primary fibroblasts. In addition, some of these
miRNAs have been shown to bypass oncogene-induced senescence in
human fibroblasts or epithelial cells (Voorhoeve et al., 2006; Borgdorff
et al., 2010; Gorospe & Abdelmohsen, 2011) and are overexpressed in
tumors (Ivanovska et al., 2008). Collectively, these results support the
notion that downregulation of these specific miRNAs is closely associated
to senescence and tumor suppression.
In a recent report, loss of Dicer was shown to lead to premature
senescence in murine fibroblasts. In this study, Dicer-induced senescence
was relayed by mechanisms different to those shown here, which
involved DNA damage and Arf-dependent activation of p53 (Mudhasani
et al., 2008). Conflicting recent reports suggest that siRNA-mediated
silencing of Dicer can trigger senescent markers in human fibroblasts
(Srikantan et al., 2011) but it can also favor bypass of oncogene-induced
senescence (Francia et al., 2012). It is well established that Dicer has
functions independent from the canonical miRNA machinery, including
heterochromatin formation, and production of noncanonical miRNA
(Winter et al., 2009). Similarly, Drosha has been reported to play a role in
ribosomal RNA processing (Liang & Crooke, 2011). It is therefore feasible
that some phenotypes associated to Dicer or Drosha depletion may
reflect miRNA-independent functions, as has been directly shown in
some cases (Francia et al., 2012). In contrast, DGCR8 participates
exclusively in the processing of canonical miRNAs and, as such, we are
confident that our results with inactivation of DGCR8 reflect bona fide
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Fig. 5 DGCR8-induced arrest in tumor cell lines. (A) Western blot analysis of the
indicated proteins after infection with an sh-DGCR8 vector or empty vector in
HCT116 colon carcinoma cells or its p53-null derivative. (B) QPCR of p21CIP1 and
DGCR8 in HCT-116 cells expressing sh-DGCR8, relative to cells with empty vector.
(C) QPCR of the indicated mature miRNAs in sh-DGCR8 HCT-116 cells relative to
vector cells. (B,C) show average and standard deviation from at least two
experiments. (D) Colony formation ability of HCT116 or HCT116-p53 KO cells after
expression of sh-DGCR8. The number of colonies was normalized to the colonies
obtained in each cell line expressing empty vector. The average and standard
deviation from three experiments are shown.
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consequences of miRNA disruption in primary fibroblasts. From a general
point of view, our results are consistent with a model where global
disruption of the miRNA machinery is associated with activation of an
antiproliferative tumor-suppressive barrier in primary cells. In apparent
contrast, it has been suggested that miRNA expression is generally
downregulated in carcinomas relative to normal tissues (Lu et al., 2005),
possibly due to defective miRNA processing (Thomson et al., 2006).
However, expression studies of miRNA regulators in cancer have failed to
give a consistent picture, with examples of downregulation, overexpres-
sion or unaltered expression of key miRNA factors in tumors (Sugito
et al., 2006; Muralidhar et al., 2007; Melo et al., 2010). It is well
established that specific miRNAs can have opposing functions in
tumorigenesis, either as oncogenes, promoting transformation, or as
tumor suppressors, preventing transformation. As exemplified in murine
embryo stem cells (Melton & Blelloch, 2010), the balance between
miRNA families with opposing roles could determine the cellular
outcome of impairment in miRNA function, also in the context of
senescence and transformation. Of note, our findings also have
implications in the context of tumors, as we show here that the ability
to arrest cell cycle in response to disrupted miRNA synthesis is retained in
tumor cells, irrespective of their p53 status. While this manuscript was
in preparation, similar effects in tumor cell lines have been reported
(Peric et al., 2012), in agreement with our work and in contrast to
previous reports suggesting the opposite effect (Kumar et al., 2007). In
summary, our data show that global miRNA disruption can trigger
cellular senescence via deregulation of specific miRNAs and key cell-cycle
regulators, highlighting the importance of miRNA-mediated regulation
in the control of this tumor-suppressive response.
Experimental procedures
Cell culture
IMR90 primary human diploid fibroblasts were obtained from the
American Type Culture Collection (ATCC). The p21-knockout and p53-
knockout MEFs were a kind gift of Manuel Serrano, CNIO, Spain. Early-
passage cells were used for all the experiments. All cells were grown in
Dulbecco’s Modified Eagles Medium (GIBCO) supplemented with 10%
fetal calf serum and containing antibiotics, at 37 °C in 5% CO2.
Retroviral and lentiviral infection
Retroviral and lentiviral transductions were performed as previously
described (Gomez-Cabello et al., 2010; Abad et al., 2011). pRetroSuper
mouse Dgcr8, pSicoR human DGCR8, pSicoR human Dicer, pSicoR
human Drosha (Kumar et al., 2007), and relevant empty vectors were
obtained from Addgene; pRetroSuper human p53 and pRetroSuper
human Rb were a kind gift of Daniel Peeper, NKI, the Netherlands.
Ectopic miRNAs were expressed using the retroviral miR-Vec vector.
BrdU incorporation
Bromodeoxyuridine (BrdU) incorporation was measured essentially as
described (Abad et al., 2011). Briefly, infected cells were plated in 8-well
glass chamber slides (LabTek, Rochester, NY, USA) at 20 000 cells per well.
Twenty-four hours later, cells were incubated with 10 lM BrdU for 6 h.
BrdU-positive cells were detected by immunofluorescence using an anti-
BrdU antibody (Megabase Research Products, Lincoln, NE, USA) and DAPI
to stain nuclei. At least 200 nuclei were counted to determine the
percentage of BrdU-positive cells.
Quantitative RT-PCR
Total RNA was isolated with Tri-Reagent (Applied Biosystem/Ambion,
Carlsbad, CA, USA), as recommended by the manufacturer. cDNA was
synthesized using M-MLV reverse transcriptase (Promega, Madison, WI,
USA). Quantitative RT-PCR was performed using one microgram of cDNA
of each condition, as described (Gomez-Cabello et al., 2010). The primers
used are available on request. QPCR of miRNAs was performed using
Exiqon or TaqMan probes according to manufacturer’s instructions.
Growth assays
For growth curves, infected cells were seeded in 24-well plates, at
20 000 cells per well, in triplicate. At the indicated time points, cells
were trypsinized and counted with a Neubauer chamber. For crystal
violet staining of plates, cells were plated at low density (5 9 104 cells
per 10-cm dish), and at 13 days postselection, they were fixed with
formaldehyde and stained with crystal violet. In some experiments, cell
number was estimated by staining with crystal violet, followed by
solubilization and measurement of absorbance at 595 nm.
UTR luciferase reporter assay
HEK293T cells were reverse transfected using Polyethylenimine (PEI;
Sigma, St. Louis, MO, USA) to individually transfect clones from the miR-
Vec library in a 96-well plate format. A 9:1 ratio of miR-Vec to luciferase
reporter construct was used. miR-Vec-Ctrl was used as control vector. A
3:1 ratio of PEI to DNA was used, and after incubation of reagent-DNA
complexes for 30 min, cells were added. Firefly and Renilla luciferase
activities were measured using the Dual-Luciferase Reporter Assay
system (Promega), 48 h after transfection.
Colony formation assay
Cells were seeded at a density of 8000 per well in 6-well plates in
triplicate. After 10 days, cells were fixed with formaldehyde and stained
with Giemsa stain solution, and colonies were counted.
Western blot
Preparation of protein lysates and immunoblot was carried out as
previously described (Palmero et al., 2002). The following antibodies
were used: DGCR8 (10996-1-AP; PTG Lab, Manchester, UK), Ras (OP-40;
Calbiochem, La Jolla, CA, USA), ERK (sc-92; Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA), Phospho-ERK (sc-7383; Santa Cruz
Biotechnology Inc.), human p53 (sc-126; Santa Cruz Biotechnology
Inc.), mouse p53 (CM5; Novocastra, Wetzlar, Germany), p21CIP1
(sc-397; Santa Cruz Biotechnology Inc.), p19Arf (54–75; gift from David
Parry, DNAX, USA), and Actin (Ac-15; Sigma).
Senescence-associated beta-galactosidase assay
Infected cells were plated at low density, fixed, and stained for
senescence-associated beta-galactosidase activity as previously described
(Dimri et al., 1995).
Immunofluorescence
Immunofluorescence was performed as described (Abad et al., 2011).
For quantification of p21-positive cells, immunofluorescence was
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performed with an antibody against p21CIP1, using an IN Cell Analyzer
1000 (GE Healthcare, Piscataway, NJ, USA), followed by image process-
ing and quantification with the IN Cell Investigators software (GE
Healthcare).
Senescence-associated heterochromatin foci
MEFs and IMR90 cells were stained with DAPI and analyzed by
microscopy to identify cells with heterochromatin foci, using at least
100 nuclei per each condition.
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Fig. S1 Antiproliferative effect of abrogation of DGCR8 in fibroblasts.
(A) QPCR analysis of the silencing efficiency of the indicated shRNA vectors,
transcript levels for Dicer, Drosha or DGCR8 was normalized to the levels in
empty vector-infected cells. (B) Long term proliferation of IMR-90 human
fibroblasts retrovirally infected with two shRNAs against DGCR8. (C) Crystal
violet staining of IMR-90 human fibroblasts retrovirally infected as in A. (D)
Growth curve of IMR-90 human fibroblasts infected with two independent
shRNAs against Dicer or Drosha, or an empty vector.
Fig. S2. (A) Western blot analysis of the indicated proteins in IMR90
fibroblasts, after infection with shRNA vectors. (B) Western blot analysis of
the indicated proteins in MEF of the indicated genotypes, after infection with
shRNA vectors. Erk, total Erk1/2 protein; P-Erk, phosphorylated Erk1/2.
Fig. S3 (A) Representative images of DAPI staining of nuclei from MEFs of the
indicated genotype, top, or IMR-90 human fibroblasts, bottom, expressing
the indicated shRNA vectors. (B) Percentage of nuclei positive for gamma-
H2AX staining in IMR-90 and BJ fibroblasts. BJ fibroblasts irradiated with
10 Gy of gamma irradiation are shown as a positive control.
Fig. S4 Schematic representation of target sequences for the indicated
miRNAs in the 3′UTR region of human p21CIP1, showing their complemen-
tarity to seed sequences of the miRNAs.
Fig. S5 (A) Relative cell number estimated by crystal violet staining of HCT-
116 and HCT-116 p53KO cells after silencing of DGCR8. (B) Western blot
analysis of the indicated proteins in U2OS or 293T cells, after infection and
selection (U2OS) or transient transfection (293T) with the indicated shRNA
vectors.
Fig. S6 Cell-cycle regulators with differential expression in shDGCR8 IMR90
cells.
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